Navigation Links
Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
Date:10/31/2008

HOUSTON, Oct. 31 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), a leading provider of cost-effective disposal solutions for small quantity generators of medical waste, today announced the appointment of John "Randy" Grow as the Company's President and Chief Operating Officer, effective October 27, 2008. Mr. Grow, who has been a member of the Company's Board of Directors since October of 2005, will retain his position on the Board. Dr. Burton Kunik will continue to hold the positions of Chairman of the Board and Chief Executive Officer.

Mr. Grow was one of the founding members and President of Accredo Health, Inc., a specialty provider of biopharmaceuticals and services. Under his leadership, Accredo grew to a $1.5 billion company after its initial public offering in 1999 until it was acquired by Medco Health Solutions. Prior to his career with Accredo Health, Mr. Grow was a Vice President with Caremark Homecare, a home infusion service provider, and American Hospital Supply, a manufacturer and distributor of surgical supplies.

Dr. Burton J. Kunik, Chairman and Chief Executive Officer of Sharps Compliance, commented, "We are facing a period of unprecedented growth in the demand for our products and services and an abundance of large sales opportunities across the nation. Not only will Randy's extensive industry experience and knowledge help us win new customer contracts, his success in guiding rapidly growing businesses will be invaluable to the successful growth and execution of our day-to-day operations."

Mr. Grow, President and Chief Operating Officer of Sharps Compliance, commented, "Burt's vision and guidance have been key components to our current industry leadership position and success to-date. I believe with the strengthened senior management team that we now have in place, we are poised for accelerated sales growth and increased profitability in the second half of fiscal 2009 and beyond."

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste and unused pharmaceuticals. The Company's flagship product, the Sharps Disposal by Mail System(R), is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market and products for the safe disposal of unused pharmaceuticals, RxTakeAway(TM). Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, commercial, and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

As a fully integrated manufacturer providing customer solutions and services, Sharps Compliance's solid business model, with strong margins and significant operating leverage, and early penetration into emerging markets, uniquely positions the company for strong future growth.

More information on Sharps Compliance can be found on its website at: http://www.sharpsinc.com.

For more information contact: - OR -

David P. Tusa Tammy Poblete

Executive Vice President, Chief Financial Kei Advisors LLC

Officer & Business Development Investor Relations

Phone: (713) 660-3514 Phone: (716) 843-3853

dtusa@sharpsinc.com tpoblete@keiadvisors.com


'/>"/>
SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
4. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
5. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
8. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
11. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):